Program

Session Time Title Chair – Faculty
Opening
A 08:30 Welcome and introduction Freek Verheugt
A 08:40 EMC – Thorax center Peter de Jaegere
VTE Chair Harry Büller
B 09:00 VTE review of trials and guidelines Michiel Coppens
B 09:30 Optimal duration of OAC after VTE and in women Saskia Middeldorp
B 10:00 Cancer and VTE (no CARAVAGGIO) Rupert Bauersachs
10:30 Panel discussion – Q & A Harry Büller
11:00 Coffee break
Keynote 11:30 CARAVAGGIO and new targets for OAC (fXIa blockers) Giancarlo Agnelli
Pulmonary Embolism Giancarlo Agnelli
C 12:00 Risk stratification in pulmonary embolism Menno Huisman
12:30 Panel discussion – Q & A Giancarlo Agnelli
13:00 Lunch and Life Case demonstration Staff Thorax center
Atrial Fibrilation Chair Freek Verheugt
D 14:00 Screening for atrial fibrillation Robert Tieleman
D 14:30 Oral anticoagulation in women Saskia Middeldorp
D 15:00 Oral anticoagulation in frail patients Martin Hemels
15:30 Coffee Break
D 16:00 t.b.a. t.b.a.
D 16:30 Real world data in special populations Jurriën ten Berg
17:00 Panel discussion – Q & A Freek Verheugt
17:00 End of Day 1

 

 

Session Time Title Chair – Faculty
08:30 Opening Freek Verheugt
Update of antithrombotic therapy Chair Werner Hacke
E 08:30 Antithrombotic therapy in stable coronary disease Freek Verheugt
E 09:00 Antithrombotic therapy post stroke Werner Hacke
E 09:30 Antithrombotic therapy in valvular heart disease Jeroen Bax
10:00 Panel discussion – Q & A Werner Hacke
10:30 Coffee break
Keynote 11:00 OAC and management of AF in ACS/PCI Renato Lopes
New strategies Chair Steven Deitelzweig
F 11:45 Antithrombotic therapy after ACS Wouter Jukema
F 12:15 Management of bleeding on oral antiacoagulation Michiel Coppens
F 12:45 Real world data Steven Deitelzweig
13:15 Panel discussion – Q & A Steven Deitelzweig
13.45 Lunch / Adjourn Freek Verheugt